Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER VENUS REMEDIES PFIZER/
VENUS REMEDIES
 
P/E (TTM) x 38.2 15.0 254.2% View Chart
P/BV x 6.0 0.9 631.1% View Chart
Dividend Yield % 1.7 0.0 -  

Financials

 PFIZER   VENUS REMEDIES
EQUITY SHARE DATA
    PFIZER
Mar-23
VENUS REMEDIES
Mar-23
PFIZER/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs4,662379 1,230.5%   
Low Rs3,407145 2,349.6%   
Sales per share (Unadj.) Rs530.0415.5 127.6%  
Earnings per share (Unadj.) Rs136.419.9 686.4%  
Cash flow per share (Unadj.) Rs159.444.0 362.1%  
Dividends per share (Unadj.) Rs70.000-  
Avg Dividend yield %1.70-  
Book value per share (Unadj.) Rs701.0344.3 203.6%  
Shares outstanding (eoy) m45.7513.37 342.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.60.6 1,207.7%   
Avg P/E ratio x29.613.2 224.4%  
P/CF ratio (eoy) x25.35.9 425.4%  
Price / Book Value ratio x5.80.8 756.6%  
Dividend payout %51.30-   
Avg Mkt Cap Rs m184,5763,501 5,271.4%   
No. of employees `000NANA-   
Total wages/salary Rs m3,317570 581.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m24,2485,555 436.5%  
Other income Rs m1,011103 979.0%   
Total revenues Rs m25,2585,658 446.4%   
Gross profit Rs m8,420602 1,398.6%  
Depreciation Rs m1,055323 326.7%   
Interest Rs m1353 4,585.0%   
Profit before tax Rs m8,240379 2,172.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,001114 1,760.5%   
Profit after tax Rs m6,239266 2,348.6%  
Gross profit margin %34.710.8 320.4%  
Effective tax rate %24.330.0 81.0%   
Net profit margin %25.74.8 538.1%  
BALANCE SHEET DATA
Current assets Rs m24,9333,230 772.0%   
Current liabilities Rs m6,574826 796.1%   
Net working cap to sales %75.743.3 175.0%  
Current ratio x3.83.9 97.0%  
Inventory Days Days9337 253.1%  
Debtors Days Days2504 0.5%  
Net fixed assets Rs m13,7802,781 495.5%   
Share capital Rs m458134 342.3%   
"Free" reserves Rs m31,6164,470 707.3%   
Net worth Rs m32,0734,603 696.7%   
Long term debt Rs m0387 0.0%   
Total assets Rs m39,0316,011 649.3%  
Interest coverage x62.1130.0 47.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.60.9 67.2%   
Return on assets %16.34.5 365.5%  
Return on equity %19.55.8 337.1%  
Return on capital %26.17.7 340.9%  
Exports to sales %2.80-   
Imports to sales %00-   
Exports (fob) Rs m688NA-   
Imports (cif) Rs m8NA-   
Fx inflow Rs m6880-   
Fx outflow Rs m80-   
Net fx Rs m6790-   
CASH FLOW
From Operations Rs m3,557366 971.1%  
From Investments Rs m-361-508 70.9%  
From Financial Activity Rs m-3,458-6 60,878.5%  
Net Cashflow Rs m-262-220 118.7%  

Share Holding

Indian Promoters % 0.0 41.8 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 18.2 1.6 1,143.4%  
FIIs % 3.0 1.6 190.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 58.2 62.0%  
Shareholders   112,456 19,560 574.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Pfizer vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Pfizer vs VENUS REMEDIES Share Price Performance

Period Pfizer VENUS REMEDIES S&P BSE HEALTHCARE
1-Day -4.80% 7.05% 1.18%
1-Month -8.24% -4.10% -0.75%
1-Year 21.78% 103.11% 61.82%
3-Year CAGR -2.07% 4.62% 18.16%
5-Year CAGR 4.95% 58.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the Pfizer share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of Pfizer hold a 63.9% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Pfizer and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, Pfizer paid a dividend of Rs 70.0 per share. This amounted to a Dividend Payout ratio of 51.3%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Pfizer, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.